Reprint
New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
Edited by
October 2019
116 pages
- ISBN978-3-03921-676-5 (Paperback)
- ISBN978-3-03921-677-2 (PDF)
This book is a reprint of the Special Issue New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges that was published in
Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.
Format
- Paperback
License
© 2019 by the authors; CC BY-NC-ND license
Keywords
anacetrapib; cholesteryl ester transfer protein; cardiovascular disease; apolipoprotein; diabetes; vaspin; acute coronary syndrome; NSTEMI; STEMI; lipoproteins; atherosclerosis; cardiovascular risk; statin; PCSK9; genetic; nutrigenetics; sterol; cholesterol; low-density lipoprotein cholesterol; cardiovascular disease; ABCA1; HDL; miRNA; circular RNA; gene expression; RNA-binding proteins; reverse cholesterol transport; cardiovascular diseases; dyslipidemia; type 2 diabetes; PCSK9; nonstatin; PCSK9; proprotein convertase subtilisin/kexin type 9; LDL subfractions; sdLDL; cardiovascular disease; risk stratification; proprotein convertase subtilisin-kexin type 9 (PCSK9); small interfering RNA (siRNA); inclisiran; low-density lipoprotein-cholesterol (LDL-C); cardiovascular disease (CVD); cardiovascular risk; atherosclerosis; ceramides; lipids; lipoproteins; miRNA; sphingolipids; sphingomyelin; NAFLD; NASH; hepatic fibrosis; hyperlipidemia; statins; statins; coronary artery bypass grafting; pleiotropic actions; atrial fibrillation; stroke; acute kidney injury